Home » Newsletters » BioWorld

BioWorld

March 4, 1994

View Archived Issues

SEQUANA AND KAISER SEEK GENETIC CAUSE OF DIABETES

THIRD PHASE I ON ARTHRITIS VACCINE

ORACLE TO INTRODUCE SALIVA-BASED HIV TEST

CENTOCOR EXTENDS ACQUISITION DATE

BLECH AND CO. EXERCISES RIBI WARRANTS

PROTEIN DESIGN LABS ANNOUNCES TRIAL RESULTS

VIRAGEN TO SEEK PRIVATE PLACEMENT

THYMOSIN ALPHA 1 IN PHASE III TRIALS

INHALE FILES FOR IPO

THYMOSIN BOOSTS IMMUNE RESPONSE

AMI, ASTRA/MERCK TEAM FOR ULCER DRUG

RAC APPROVES TWO TRIALS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...